Pharmafile Logo
Pharmafocus logo
Advanced Search

pershing

Showing 2 posts of 2 posts found.

Allergan image

Allergan rejects Valeant – again

June 11, 2014
Research and Development, Sales and Marketing Allergan, Botox, Valeant, pershing, pharma

Allergan and Valeant Pharmaceuticals International are continuing their stately dance around one another – and in the latest move the …

News
Allergan image

Valeant makes $45.7 billion Allergan offer

April 23, 2014
Sales and Marketing Allergan, Botox, GSK, Novartis, Pfizer, Valeant, merger, pershing

In the latest proposal in a flurry of merger and acquisition activity in the pharma sector, Valeant Pharmaceuticals International wants …

News
The Gateway to Local Adoption Series

Latest content

STADA and Bio-Thera’s Gotenfia receives positive CHMP opinion for autoimmune diseases

December 18, 2025

Norgine enters exclusive licensing agreement with Vir Biotechnology

December 18, 2025

Incyclix appoints Kimberly Blackwell to Board of Directors

December 17, 2025

Hansa Biopharma appoints Max Sakajja as Vice President, General Manager Europe and International

December 17, 2025

GSK’s Exdensur receives MHRA approval for asthma and rhinosinusitis

December 16, 2025